CRZBY News Alert Commerzbank Ag Ads (CRZBY) 13.4400 12/25/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Commerzbank Ag Ads (CRZBY) 13.4400 $CRZBY

Wall Street Breakfast: PetSmart Acquired For $8.7B In Mega PE Deal
Wall Street Breakfast - Seeking Alpha - Mon Dec 15, 5:31AM CST
Outstanding Performance Article Rewards We're excited to announce our latest two Outstanding Performance award winners. Each author receives $2,500. Read more about our Outstanding Performance award winners here . Winner #1: Long idea on ...
ECR: 6.98 (+0.09), BT: 64.37 (+0.17), HAL: 39.70 (-0.18), CZR: 15.44 (+0.20), ADBE: 74.74 (+0.36), AVID: 14.36 (+0.26), SPY: 207.77 (+0.02), BIDU: 230.98 (-2.18), QQQ: 104.30 (+0.09), TEF: 14.81 (-0.02), MSFT: 48.14 (-0.31), ORAN: 17.52 (-0.04), CSCO: 28.30 (+0.05), BHI: 56.34 (-0.10)

Wall Street Breakfast: European Shares Sink As Oil Extends Slump
Wall Street Breakfast - Seeking Alpha - Fri Dec 12, 5:31AM CST
Economy European stocks are on the decline as commodity prices continued to fall while the take-up of the ECB's latest cheap money program, known as TLTROs, met expectations on Thursday, but was still disappointing compared to earlier...
ECR: 6.98 (+0.09), BT: 64.37 (+0.17), HAL: 39.70 (-0.18), CZR: 15.44 (+0.20), ADBE: 74.74 (+0.36), AVID: 14.36 (+0.26), SPY: 207.77 (+0.02), BIDU: 230.98 (-2.18), QQQ: 104.30 (+0.09), TEF: 14.81 (-0.02), MSFT: 48.14 (-0.31), ORAN: 17.52 (-0.04), CSCO: 28.30 (+0.05), BHI: 56.34 (-0.10)

European Stocks Decline as Global Oil Demand Forecasts Are Lowered
at The Street - Fri Dec 12, 5:28AM CST
European stocks are bleeding red again on Friday amid flat eurozone industrial production and a lower forecast for global oil demand in 2015.
ENI: 16.17 (+0.16)

Commerzbank nears $1B+ settlement with U.S.
Seeking Alpha - at Seeking Alpha - Fri Dec 12, 12:58AM CST


Commerzbank: Why Hundreds Of German Savers Are Bringing Commerzbank To Trial
Daniel Gilcher - at Seeking Alpha - Fri Nov 14, 4:47PM CST


European Stocks Trade Lower After 25 Banks Fail Stress Tests
at The Street - Mon Oct 27, 5:48AM CDT
European stocks are slipping after 25 banks failed stress tests by the European Central Bank.

KKR & Borealis Maritime Buy 9 Ships from Commerzbank - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Aug 29, 5:15PM CDT
Kohlberg Kravis announced the purchase of a shipping portfolio containing nine feeder container vessels in partnership with Borealis Maritime in a deal coordinated by the German bank Commerzbank (CRZBY).
NBG: 1.95 (+0.06), KKR: 23.14 (+0.24)

Why Commerzbank (CRZBY) Stock Is Sinking This Morning
at The Street - Thu Jul 10, 9:19AM CDT
the German lender is expected to pay between $600 million and $800 million to resolve investigations into its dealings with Iran and other countries under U.S. sanctions.

Why Deutsche Bank (DB) Stock Is Falling Today
at The Street - Tue Jul 08, 9:09AM CDT
Deutsche Bank (DB) shares are down following reports that it is negotiating a settlement with U.S. regulators over money laundering accusations.
DB: 30.95 (+0.04)

Which Institutions Are Buying Up Spain?
Alexander MacLennan, The Motley Fool - Motley Fool - Fri Jul 04, 6:25AM CDT
In two other parts of this series, I discuss the contrarian investors buying up assets in Ireland and Greece . In this part I will discuss who's buying and who's selling Spanish assets following the nation's economic downturn. Economic troubles...
GS: 195.89 (+0.39), BX: 34.01 (+0.05), JPM: 62.48 (unch), FIG: 7.89 (unch)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 232

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 136

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 104

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 373

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
KINGRVER Boosts RV Comfort with New Water Heater Lineup

Updated Category News Views 103

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 0

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 49

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 133

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
Pan-Mass Challenge Gifts $80M to Dana-Farber for 2026

Updated Category News Views 38

A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...

Continue Reading
Princess Cruises Launches New Era at Celebration Key

Updated Category News Views 135

Never thought I'd see the day when a cruise ship docking would stir such excitement, but here we are. The Star Princess has made its grand debut at Celebration Key, the latest jewel in Princess Cruises' crown. And they're going all out with Bahamian flair—something about a Junkanoo band and beach art that would make even the crustiest sailor crack a smile. Inaugural Fun...

Continue Reading

Top 5 Most Recently Viewed Articles

Cassava Sciences Takes Strategic Steps Amid Clinical Developments

Updated Category News Views 241

Cassava Sciences Provides Key Business Update Cassava Sciences, Inc. (NASDAQ: SAVA), a biotechnology company dedicated to developing innovative treatments for central nervous system disorders, has shared an important business update that affects both its operations and strategic direction. Important Study Results and Future Plans Recent data from the Phase 3 RETHINK-ALZ...

Continue Reading
ColdVentures Welcomes Dr. Barrak Alahmad as Strategic Advisor

Updated Category News Views 164

ColdVentures Expands Leadership with Key Appointment ColdVentures, a pioneering medical device company focused on addressing heat-related illnesses, has taken a significant step forward by appointing Dr. Barrak Alahmad as a strategic advisor. Dr. Alahmad, known for his expertise in environmental health and climate change, brings a wealth of knowledge to the role,...

Continue Reading
Season Group Hits Top 15% with EcoVadis Silver Medal

Updated Category News Views 40

Season Group's Silver Medal Moment Well, it's not every day that a company gets a pat on the back for actually doing something good, but that's what you have here with Season Group snagging the EcoVadis Silver Medal. It’s like the Oscars for sustainability, and it puts them in the top 15% of companies assessed globally by these sustainability gurus. That’s a title...

Continue Reading
LSPedia Achieves Notable Recognition in Business Category

Updated Category News Views 144

LSPedia Celebrated for Excellence in Business LSPedia is thrilled to announce its recent inclusion in Inc.'s 2024 Best in Business list, specifically in the Software as a Service category. This prestigious recognition highlights organizations that are industry leaders and stand out for their impactful achievements. A Testament to Industry Leadership In recognizing...

Continue Reading
Bev Colan Appointed as President of Venn Workforce Optimization

Updated Category News Views 216

Venn Workforce Optimization Welcomes New Leadership In an exciting development for Venn Workforce Optimization, Bev Colan has been named the company president. This marks a significant step for the organization, which specializes in locum tenens optimization and workforce solutions technology. Bev Colan: A Proven Leader Bev Colan joins the Venn team with over 20 years of...

Continue Reading